20th Annual CRI Cancer Immunotherapy Symposium

About the International Cancer Immunotherapy Series

Inaugurated in 1993, the Cancer Research Institute International Cancer Immunotherapy Symposium Series is designed to accelerate the understanding and development of immune system-based therapies for cancer by convening the field's leaders to share the most up-to-date data on topics of current relevance in the field. These annual meetings, originally developed under the leadership of Lloyd J. Old, M.D., focus attention on progress in the two central approaches of cancer immunology -- cancer vaccines and antibody-based therapies.
About Cancer Immunotherapy 2012

From Milestones to Medicines: Translating Tumor Immunology Research into Immunotherapies, will feature three days of plenary lectures by the world's leading immunologists and tumor immunologists. The meeting will be divided into six sessions and will explore the latest findings in the following areas: Antibodies, Adjuvants, Neoantigens, Vaccines & Genomics, Immune Modulation by Stroma, Other Topics that Impact Immunity, and Emerging Technologies. This year also marks the 20th anniversary of the Symposia Series and the meeting will be dedicated to Dr. Old.

Cancer Immunotherapy 2012 Planning Committee:
James Allison, Memorial Sloan-Kettering Cancer Center, New York, NY
Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA
Carl Nathan, Weill Medical College of Cornell University, New York, NY
Herbert Oettgen, Memorial Sloan-Kettering Cancer Center, New York, NY
Ellen Puré, The Wistar Institute, Philadelphia, PA
Robert Schreiber, Washington University School of Medicine, St. Louis, MO
Jedd Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY
About the Cancer Research Institute

The Cancer Research Institute was founded in 1953 to foster the science of cancer immunology. It is the world's only non-profit organization dedicated exclusively to the support and coordination of laboratory and clinical efforts that will lead to the immunological treatment, control, and prevention of cancer. As the initiator and steward of unprecedented global scientific and clinical collaboration, the Cancer Research Institute is ushering a new era of scientific progress, hastening the discovery of effective cancer vaccines and other immune-based therapies that are providing new hope to patients.


Important Dates to Remember

Friday, August 10, 2012 Poster Abstract Submission Deadline
Early Registration Deadline

Tuesday, September 4, 2012 Last Day for Group Rate at Millennium Hotel

 

Contact Information

  • Cancer Research Institute
    Phone: (212) 688-7515
    Email: meetings@cancerresearch.org

    Meeting Location:

    Millennium Broadway Hotel 
    145 West 44th Street
    New York, NY 10036
    United States


Payment Instructions

  • All major credit cards are accepted. If you are paying by check, please make checks payable to Cancer Research Institute (U.S. funds drawn on U.S. banks only). Mail a copy of your registration with your check to:

    2012 Symposium
    Cancer Research Institute
    One Exchange Plaza
    55 Broadway, Suite 1802
    New York, NY 10006

    Requests for refunds must be submitted in writing by Monday, September 17, 2012 to meetings@cancerresearch.org. Refund requests received after that date will not be honored. There will be a $100 processing fee for all refunds. Registrations are non-transferable.

    For registration inquiries, please call the Cancer Research Institute at (212) 688-7515 or write to meetings@cancerresearch.org.